SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Hyaluronic Acid Fillers from Safety and Complications to Clinical Outcomes: Scoping Review with ☸️SAIMSARA.

Skin & Aesthetics

Skin & Aesthetics

Issue 8, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsara82466501

Editorial note
• Last update: 2026-05-16 12:29:59
What is this paper about
Hyaluronic acid fillers are more than simple volumizers: their real clinical value depends on product rheology, anatomical placement, imaging guidance, and rapid complication rescue. The full evidence map helps separate durable aesthetic and reconstructive benefits from the safety boundaries that matter most in practice, including vascular occlusion, delayed inflammation, migration, hyaluronidase response, and rare ocular or neurologic events.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.
Found an issue in this paper? Email admin@saimsara.com

Evidence preview · Did you know?
Realistic dermatology scene showing hyaluronic acid filler treatment and skin remodeling concept.

Fillers may remodel skin

Did you know? HA fillers may do more than add volume: collagen increased by 34.2% at 3 months and 39.5% at 9 months after injection.

This shifts the clinical story from simple filling toward tissue response, dermal remodeling, and product-specific biology.

Realistic medical imaging scene showing long-term hyaluronic acid filler persistence in facial soft tissue.

They may last longer than expected

Did you know? HA filler was found histologically more than 10 years after injection in some patients.

Longevity, migration, imaging visibility, and diagnostic mimics become part of the real-world safety map.

Realistic clinical safety scene showing facial vascular anatomy, injection planning, and emergency complication awareness.

Tiny volumes can be catastrophic

Did you know? About 0.04 mL of filler was enough to completely block the ophthalmic artery in a cadaveric model.

This is why anatomy, vascular mapping, injection technique, and rescue pathways matter as much as aesthetic outcome.

Swipe sideways on mobile · full evidence map opens after unlock

Abstract: To synthesize current evidence regarding hyaluronic acid filler. The review uses 299 references and builds its evidence map from 514 original studies with 241381 total participants/sample observations (topic-deduplicated ΣN). This scoping review suggests that HA fillers function as a versatile and generally effective soft-tissue platform whose clinical performance is governed more by product-specific rheology, anatomical placement, and complication preparedness than by HA as a uniform class. Recurrent signals support durable aesthetic and functional improvement across facial, genital, and reconstructive indications over 6–12 months, while vascular occlusion, delayed inflammatory reactions, and rare ocular or neurologic events remain the defining safety boundaries. The evidence supports a practical workflow combining product-matched selection, image-guided injection, and rapid hyaluronidase-centered rescue. Because much of the safety literature is built from case reports and small series, future work should prioritize prospective multicenter registries and image-guided comparative trials to clarify real-world risk and refine rescue protocols.

Keywords: Hyaluronic acid filler; Dermal fillers; Aesthetic medicine; Facial injection; Soft tissue augmentation; Vascular occlusion; Delayed inflammatory reactions; Ultrasound guidance; Magnetic resonance imaging; Hyaluronidase

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (299)
Article views: —
Follow us

© 2026 SAIMSARA Journal Impressum Published by ML in Health Science GbR